Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Amortization of Deferred Charges (2024 - 2025)

Historic Amortization of Deferred Charges for Ensysce Biosciences (ENSCW) over the last 2 years, with Q1 2025 value amounting to $300000.0.

  • Ensysce Biosciences' Amortization of Deferred Charges fell 7439.1% to $300000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $300000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 26706.92% up from last year.
  • Latest data reveals that Ensysce Biosciences reported Amortization of Deferred Charges of $300000.0 as of Q1 2025, which was down 7439.1% from $25735.0 recorded in Q2 2024.
  • In the past 5 years, Ensysce Biosciences' Amortization of Deferred Charges ranged from a high of $1.2 million in Q1 2024 and a low of $25735.0 during Q2 2024